Combination Agent P2B001 Shows Promise for Parkinson Disease in Phase 3 Data

Press/Media

Period	5 Apr 2022

Media coverage

Title	Combination Agent P2B001 Shows Promise for Parkinson Disease in Phase 3 Data
Media name/outlet	Neurology Live
Country/Territory	United States
Date	5/04/22
URL	https://www.neurologylive.com/view/combination-agent-p2b001-promise-parkinson-disease-phase-3-data
Persons	C. Olanow